Security key
56270V205
MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (MGRX)
CUSIP: 56270V205
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 28,206
- Total 13F value
- $10,718
- Share change
- +26,863
- SEC-reported price per share
- $0.38
- Number of holders
- 2
- Value change
- +$10,208
- Number of buys
- 1
- Shares outstanding
- 14,002,438
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
2
Top holders
2
MGRX full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
MANGOCEUTICALS, INC. SEC filings
MANGOCEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 56270V205
Recent filing periods:
Ownership snapshot
Top reported holders of MGRX - MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Jacob D. Cohen
Disclosed value leader
Jacob D. Cohen
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 15%
13D/G row: Jacob D. Cohen
Showing 1-6 of 15 holder rows.
Quick read
Jacob D. Cohen leads the comparable SEC ownership view at 15%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Jacob D. Cohen's linked filing trail.
Comparable ownership
Top 5
Jacob D. Cohen
15%
GREENFIELD INVESTMENTS LTD.
14%
Dr. Kenny Myers
0.98%
Lorraine Pamela D'Alessio
0.98%
Eugene M. Johnston
0.86%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Jacob D. Cohen |
13D/G
3/4/5
Chief Executive Officer, Director, 10%+ Owner
|
15%
|
$4,599,801
2,044,356 shares
|
+$2,526,052 | 21 Jul 2025 |
| GREENFIELD INVESTMENTS LTD. |
13D/G
|
14%
|
$916,700
515,000 shares
|
$0 | 13 Dec 2024 |
| Dr. Kenny Myers |
3/4/5
Director
|
0.98%
|
$232,333
136,667 shares
|
— | 09 Sep 2025 |
| Lorraine Pamela D'Alessio |
3/4/5
Director
|
0.98%
|
$232,333
136,667 shares
|
— | 09 Sep 2025 |
| Eugene M. Johnston |
3/4/5
CFO
|
0.86%
|
$139,836
120,000 shares
|
-$21,139 | 15 Dec 2025 |
| Alex P. Hamilton |
3/4/5
Director
|
0.02%
|
$4,077
3,334 shares
|
-$152,875 | 19 Nov 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
28,206
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
18
Q2 2026 holders
2
Holder diff
-16
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend